Using artificial intelligence as a discovery tool, researchers have discovered that the hormone melatonin could offer protection against both aging and Alzheimer’s disease (AD).They say their study sets out a reproducible “AI-to-clinic” paradigm that can provide breakthroughs towards clinically effective therapeutics targeting the intertwined complexities of aging and AD.The findings demonstrate how sophisticated computational frameworks […]
